Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients
Open Access
- 18 February 2021
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (1), 2002724
- https://doi.org/10.1183/13993003.02724-2020
Abstract
A fraction of COVID-19 patients progress to a severe disease manifestation with respiratory failure and the necessity of mechanical ventilation. Identifying patients at risk is critical for optimized care and early therapeutic interventions. We investigated the dynamics of SARS-CoV-2 shedding relative to disease severity. We analyzed nasopharyngeal and tracheal shedding of SARS-CoV-2 in 92 patients with diagnosed COVID-19. Upon admission, standardized nasopharyngeal swabs or sputum were collected. If patients were mechanically ventilated, tracheal aspirates were additionally obtained. Viral shedding was quantified by real-time PCR detection of SARS-CoV-2 RNA. 45% (41 of 92) of COVID-19 had a severe disease course with the need for mechanical ventilation (severe group). At week 1, the initial viral shedding determined from nasopharyngeal swabs showed no significant difference between non-severe and severe cases. At week 2, a difference could be observed as the viral shedding remained elevated in severely ill patients. A time course of C-reactive-Protein (CRP), Interleukin-6 (Il-6), and Procalcitonin (PCT) revealed an even more protracted inflammatory response following the delayed drop of virus shedding load in severely ill patients. A significant proportion (47.8%) of patients showed evidence of prolonged viral shedding (>17 days), which was associated with severe disease courses (73.2%). We report that viral shedding does not differ significantly between severe and non-severe cases upon admission to the hospital. Elevated SARS-CoV-2 shedding in the second week of hospitalisation, a systemic inflammatory reaction peaking between second and third week and prolonged viral shedding are associated with a more severe disease course.This publication has 44 references indexed in Scilit:
- Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and futureBMC Medicine, 2011
- Prognostic value of procalcitonin in community-acquired pneumoniaEuropean Respiratory Journal, 2010
- Immunity and immunopathology to viruses: what decides the outcome?Nature Reviews Immunology, 2010
- Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infectionEuropean Respiratory Journal, 2010
- Detection of multiple respiratory pathogens during primary respiratory infection: nasal swab versus nasopharyngeal aspirate using real-time polymerase chain reactionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Detection of SARS Coronavirus in Patients with Suspected SARSEmerging Infectious Diseases, 2004
- Interleukin-6-dependent and -independent regulation of the human C-reactive protein geneBiochemical Journal, 1997
- Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivoBiochemical Journal, 1997
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994
- High serum procalcitonin concentrations in patients with sepsis and infectionThe Lancet, 1993